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1. Introduction
Alzheimer’s disease (AD) is the utmost common form of dementia, a usual term 
for memory defect and other cognitive impairments that seriously affect daily life 
[1]. This degenerative disease is accountable for 60–80% of dementia cases. AD is 
not a typical part of normal aging. The supreme well-known threatening factor is 
aging, and the mainstreams of people with AD are 65 years and older [2]. In fact, 
AD is not considered as a disease of adulthood. AD and other types of dementia 
affect a predictable 1 in 14 persons over the 65 year of age and 1 in every 6 persons 
over 80 years of age. But, about 1 in every 20 cases of AD affects people with in age 
ranging 40–65 years, which is called early-onset AD.
AD is a progressive disease that deteriorates over time, and symptoms of 
dementia steadily exacerbate. In its initial stages, memory defect is mild, but over 
a number of years in late-stage, AD patients lose the aptitude to convey a message 
and reply to their surroundings [3]. AD is the sixth foremost cause of death in the 
USA. Patients with AD may live an average of 8 years after the symptoms are visible 
to others, but the survival rate is higher; it can range from 4 to 20 years, based on 
aging and other health situations [4].
AD is still incurable, but current treatment strategies can momentarily reduce 
the deterioration of the symptoms and progress of the quality of life of the 
patients. Today, there is a universal effort to find better ways to treat the develop-
ment and progression of AD. The purpose of this chapter is to give an overview 
of AD.
2. Alzheimer’s and the brain
The brain has billions of nerve cells called neurons attached with each other to 
construct communication network. There are several groups of nerve performing 
specific jobs like thinking, learning, remembering, smelling, etc. [5].
To perform their job, like the receiver of supplies, generation of energy, con-
struction of equipment, and disposal of waste, neurons operate like tiny factories. 
Brain cells also reserve, process information, and connect with other cells. In order 
to keep all of these running, they require a huge amount of fuel and oxygen as well 
as coordination.
Efforts of a lot of researchers are going on to untangle the complicated changes 
of the brain happened in the early stage and advancement of AD (Figure 1). 
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It seems feasible that brain degradation starts a decade or more before memory 
deficit and other cognitive dysfunctions actually appear. Throughout the early stage 
of AD, patients do not display any symptoms; however, cytotoxic turns do appear in 
the brain. Senile plaques (SPs) and neurofibrillary tangles (NFTs) are formed due 
to abnormal deposition of proteins that result in discontinued function of neurons, 
failed internetwork, and ultimately neuronal death [6].
The hippocampus is the part of the brain having the vital role in generating 
memories and seems to be affected initially, and later, the damage spreads out to 
all other parts of the brain [7]. As a result, the brain starts to shrink. Moreover, 
significant widespread damage and shrunk in the brain tissues appear in the final 
stage of AD.
3. Causes of Alzheimer’s disease
The main reason of AD is not completely understood till now. Approximately 
70% reason for Alzheimer’s is genetic [8, 9]. A number of factors are supposed to 
raise the risk of developing the condition such as:
• Family history
• Untreated depression
• Lifestyle-related factors linked with cardiovascular events
4. Signs and symptoms of Alzheimer’s disease
With age, changes in the brain as well as rest of the body cells are obvious. Most 
of us in general notice such kind of changes by facing difficulties like losing the 
capacity of thinking and/or remembering certain things.
Figure 1. 
The normal aged brain and the brain of an Alzheimer’s patient.
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Difficulties in remembering newly known things and information are the most usual 
early feature shown in AD, because in the initial stage of Alzheimer’s changes occur in 
the area of the brain involved in learning [10]. In advance stage of the AD, brain changes 
cause generation of progressively awful symptoms, including disorientation,  
behavior, and mood changes; deepening skepticism about events, location, and time; 
baseless doubts about family, friends, and professional caregivers; serious loss of mem-
ory; and difficulties in the everyday jobs like swallowing, speaking, walking, etc. [11].
There are numerous threatening signs and symptoms of AD. Every people may 
notice one or more of these signs in a diverse degree:
• Memory deficit that interrupts daily life
• Alterations in planning or problem solving ability
• Trouble in doing routine works at home and work
• Misperception about place and time
• Trouble in the visualization and spatial dealings
• Difficulty in speaking or writing
• Forgetting things and reducing the capacity to repeat phases
• Reduction of judgment skill
• Alteration of personality and mood
• Separation from social events or works
5. Pathological Hallmarks of Alzheimer’s disease
The SPs consist primarily of amyloid β (Aβ) and neurofibrillary tangles (NFTs), 
consist of tau proteins are the abnormal structures considered as suspects for the 
damage of brain cells. Aβ is derived from the amyloid precursor protein (APP), 
which is cleaved by beta secretase and gamma secretase, and NFTs are the aggre-
gates of hyperphosphorylated tau protein [12].
A lot of people develop plaques and tangles along with age, as shown by autopsy 
studies. Patients with Alzheimer’s have the potential to spread into far more areas 
by plaques and tangles in a foreseeable pattern [5]. In fact, first, these pathological 
hallmarks appear in the area of memory before spreading to the other regions.
The impact of plaques and tangles in AD still remains unclear. Most of the 
researchers believe that they somehow play a complex pathogenic role in AD to 
block the network of brain cells and interrupts the processes required for cell 
survivals [13]. The destruction and death of nerve tissues are the causes of failure of 
the memory, personality changes, and other difficulties to carryout usual activities 
in everyday life and other symptoms of AD.
6. Alzheimer’s and typical age-related changes
In case of most people, the sporadic decrease in memory is measured as a typical 
part of the aging, which is not a threatening sign of stern mental failure or the onset 
of dementia (Table 1).
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The memory deficits that are usual amid older adults and usually are not 
reflected as caution signs of dementia is presented below:
• Becoming easily blurred
• Rarely forgetting an appointment
• Entering into a room and forgetting the reason for entrance
• Unable to recover info that are on the tip of the tongue
• Worried to remember just read info or the details of a chat
• Abruptly forgetting where things of common use (such as keys) have been kept
• Fail to recall names of acquaintances or difficulty in one memory with a similar 
one, such as calling a grandson by his/her son’s name
7. Diagnosis of Alzheimer’s disease
The person with age group older than 80 years if diagnosed with AD can survive 
at least 3–4 years, whereas younger peoples can stay alive usually about more than 
10 years [15].
Various methodologies and tools are deployed by the physician to identify the 
actual problem such as the possible AD or probable AD.
To diagnose AD, usually physicians may:
• Ask the patient and the family member or close contacts about the health status, 
past medical history, capability to perform daily works, and alteration in behav-
ior and personality
• Conduct tests of memory, attention, language, problem-solving, and counting 
ability
• Conduct other tests like blood and urine tests, to find other likely reasons for 
the problem
• Perform the scans of the brain like computed tomography, positron emission 
tomography, magnetic resonance imaging, or other tests to detect the promising 
causes for symptoms
Signs of Alzheimer’s/dementia Typical age-related changes
Poor judgment and decision-making Making a bad decision once in a while
Inability to accomplish a budget Missing a monthly payment
Losing trail of the date or the season Forgetting which day it is and remember it later
Trouble having a conversation Occasionally forgetting which word to use
Misplacing things and being unable to retrace steps to 
find them
Losing things from time to time
Table 1. 
The differences between AD and typical age-related changes [14].
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These tests are effective to identify how the person’s memory and other cognitive 
functions are altering over time. However, AD can be certainly diagnosed only after 
the death of the patient, by relating the clinical events with the autopsy of the brain.
If a person has memory problems, they must consult a physician related to their 
problems so as to facilitate the physician to diagnose whether it is AD or any other 
issues such as Parkinson’s disease, stroke, sarcoma, adverse effects of medicines, or a 
non-Alzheimer’s. Few of these diseases are curable and conceivably revocable.
If the disease is diagnosed in its early phase, it may be treatable and very helpful 
for future plans such as economic and legislative matters, becoming habituated to 
living measures and developing the buttress networks.
Furthermore, the participation of patients in clinical trials is also one of the advan-
tages of early diagnosis because it makes newer researches and treatments for AD.
8. Treatment of Alzheimer’s disease
Due to the complexity of AD, its treatment by only one drug or other medica-
tion is not possible. Therefore, the pivotal strategy is to help the patient to maintain 
intellectual function and behavior as well as mitigate the specific concerns like 
reduction of memory deficits [7]. Newer therapies are expected to be establish by 
researchers to target the peculiar genetic, molecular and cellular mechanism which 
can stop the intrinsic genesis of the disease.
Psychological treatments like cognitive stimulation therapy are also helpful to 
improve memory, language ability as well as problem resolving talents.
9. Prevention of Alzheimer’s disease
The exact reason for the pathogenesis of AD is still anonymous [16]. But 
researchers put their efforts to minimize hazards or postponement of the onset of 
dementia, and suggested the following that can reduce the chance of dementia:
• Stopping smoking
• Reducing alcohol consumption habit
• Eating a balanced diet as well as maintaining weight
• Staying physically and mentally fit and active
Not only AD, these events have other health aids, such as reducing the risk of 
numerous diseases especially cardiovascular disorders and improving the overall 
health status.
10. Research and progress
Nowadays, studies are focusing to detect the exact etiology of plaques deposi-
tion, tangles formation, and associated with other biological landscapes of AD [7]. 
The development and progress of Aβ and NFTs in the living brain, as well as the 
change in brain anatomy and activity, can be observed with the help of existing 
brain scan techniques. With the help of the results obtained by studying the altera-
tions that take place in the brain along with body fluids, researchers evaluate the 
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initial steps involved in the disease progress prior to the appearances of Alzheimer’s 
symptoms that give information about the root cause of AD as well as also facilitates 
its diagnosis.
The utmost enigma of AD is why it mostly attacks older is still a great obscure 
[7]. Research on the typical aging of the brain is making this question transparent. 
Researchers are learning how age-linked variations in the brain may damage neu-
rons and contribute to AD. The alterations caused due to atrophy (i.e., shrinking) in 
some area of the brain, infections, release of free radicals as well as the mitochon-
drial defect (some deformities in the powerhouse of the cell causes unnecessary 
breakdown of energy molecules and results in the loss of energy). These alterations 
in old age people enlighten the reason why adults are susceptible to AD.
11. Conclusion
Current studies are working to elucidate copious aspects of AD and dementia. 
About 90% of what we know about AD has been discovered in the last 20 years. The 
greatest auspicious progress in AD research is how it affects the brain. There is hope 
that this superior understanding of the pathogenic mechanism will lead to better 
treatment strategy with minor adverse/side effects. At present numerous latent 
approaches are under study worldwide.
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